NCAC
Newcourt Acquisition Corp - Ordinary Shares - Class A

21
Mkt Cap
$10.79M
Volume
91,904.00
52W High
$14.55
52W Low
$4.58
PE Ratio
-189.33
NCAC Fundamentals
Price
$4.79
Prev Close
$5.69
Open
$6.28
50D MA
$9.52
Beta
0.01
Avg. Volume
22,033.52
EPS (Annual)
-$0.0253
P/B
-12.04
EV/EBITDA
-37.23
Loading...
Loading...
News
all
press releases
Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process
NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp ( Newcourt ) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the Business...
Globe Newswire·2y ago
News Placeholder
More News
News Placeholder
Newcourt Acquisition Corp trading resumes
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Newcourt Acquisition Corp trading halted, volatility trading pause
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Newcourt Acquisition Corp trading resumes
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Newcourt Acquisition Corp trading halted, volatility trading pause
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group") (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in...
Globe Newswire·2y ago
News Placeholder
Newcourt Acquisition Corp trading halted, volatility trading pause
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest NCAC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.